PRESS RELEASE published on 02/02/2026 at 09:00, 6 months 17 days ago Original-Research: Hoenle AG (von NuWays AG): BUY Hoenle AG's research update by NuWays AG reveals FY 24/25 results and FY 25/26 expectations, highlighting revenue and EBITDA trends across Disinfection, Adhesives, and Curing segments NuWays AG Research Update Hoenle AG FY 24/25 Results FY 25/26 Expectations
BRIEF published on 12/10/2025 at 09:05, 8 months 9 days ago Hoenle AG : Avancées stratégiques dans un contexte de marché difficile Stratégie De Croissance Prévisions Financières Technologie UV Leadership Du Marché Hoenle AG
BRIEF published on 12/10/2025 at 09:05, 8 months 9 days ago Hoenle AG: Strategic Advances Amid Challenging Market Conditions Growth Strategy Financial Forecast Market Leadership UV Technology Hoenle AG
PRESS RELEASE published on 12/10/2025 at 09:00, 8 months 9 days ago Original-Research: Hoenle AG (von NuWays AG): BUY NuWays AG updates research on Hoenle AG, recommending BUY with a target price of EUR 15.00. Hoenle leads in UV curing devices, offering solutions in adhesives, curing, and disinfection, focusing on niche markets Investment NuWays AG Research Hoenle AG UV Curing
BRIEF published on 12/03/2025 at 09:05, 8 months 16 days ago Hoenle AG Poised for Growth Amid Strategic Shifts EBITDA Margin Sales Growth Strategic Transformation Hoenle AG Disinfection Business
BRIEF published on 12/03/2025 at 09:05, 8 months 16 days ago Hoenle AG prête pour la croissance malgré des changements stratégiques Croissance Des Ventes Marge D'EBITDA Transformation Stratégique Hoenle AG Entreprise De Désinfection
PRESS RELEASE published on 12/03/2025 at 09:00, 8 months 16 days ago Original-Research: Hoenle AG (von NuWays AG): BUY Update on Hoenle AG by NuWays AG highlighting FY24/25 figures meeting guidance, FY25/26 growth expectations, strong EBITDA margin, and long-term prospects. Company poised for strategic transformation EBITDA Margin NuWays AG FY24/25 Hoenle AG FY25/26
Published on 08/19/2026 at 09:05, 2 hours 38 minutes ago BioNxt Advances Cladribine Clinical Program with Completion of the Investigational Medicinal Product Dossier (IMPD) Ahead of Human Clinical Studies
Published on 08/19/2026 at 07:00, 4 hours 43 minutes ago Caldwell Strengthens Life Sciences and Healthcare Practice with Addition of Olga Kozlova in Dubai
Published on 08/19/2026 at 04:00, 7 hours 43 minutes ago Momenta, XHEART, and QNX Build an Autonomous Driving Platform Certified to Global Safety Standards
Published on 08/18/2026 at 23:10, 12 hours 33 minutes ago Secure Blockchain Signs Agreement to Sell Delivery Trust(R) Business
Published on 08/18/2026 at 19:45, 15 hours 58 minutes ago ECC Ventures 5 Corp. Enters Into Business Combination Agreement with Bayrock Resources for Qualifying Transaction
Published on 08/19/2026 at 11:06, 37 minutes ago Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 08/19/2026 at 11:05, 38 minutes ago HMS Bergbau AG announces preliminary financial results for the first half of 2026
Published on 08/19/2026 at 11:00, 43 minutes ago Shelly Group Strengthens European Market Reach Through Partnership with Leading Technology Distributor ALSO
Published on 08/19/2026 at 10:05, 1 hour 38 minutes ago Colt Data Centre Services Appoints Quy Nguyen as Chief Executive Officer
Published on 08/19/2026 at 10:00, 1 hour 43 minutes ago The notes redeemed by Municipality Finance have been removed from trading at Nasdaq Helsinki
Published on 08/18/2026 at 18:00, 17 hours 43 minutes ago KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 17 hours 58 minutes ago Mise à disposition du rapport financier annuel 2025-26
Published on 08/18/2026 at 11:15, 1 day ago GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 10 au 14 août 2026
Published on 08/18/2026 at 11:15, 1 day ago GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026
Published on 08/17/2026 at 19:45, 1 day 15 hours ago Aéroports de Paris S.A - July 2026 traffic figures
